Capecitabine combined with oxaliplatin (XELOX) as first line chemotherapy in colorectal cancer with liver metastases

被引：0
|
作者：
Mahfouf, H.
Djedi, H.
Oukkal, M.
Bouzid, K.
Bentabak, K.
Graba, A.
Chaher, N.
Ait, Kaci N.
Terki, N.
机构：
[1] EHS Ctr Pierre & Marie Curie, Dept Med Oncol, Algiers, Algeria
[2] EHS Ctr Pierre & Marie Curie, Dept Surg, Algiers, Algeria
[3] EHS Ctr Pierre & Marie Curie, Dept Pathol, Algiers, Algeria
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：VII42 / VII42
页数：1
相关论文
共 50 条
  • [1] Capecitabine combined with oxaliplatin (XELOX) as first-line chemotherapy in colorectal cancer with liver metastases
    Mahfouf, H.
    Djeddi, H.
    Belhadef, S.
    Bouzid, K.
    Bentabak, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients
    Coskun, U.
    Buyukberber, S.
    Yaman, E.
    Uner, A.
    Er, O.
    Ozkan, M.
    Dikilitas, M.
    Oguz, M.
    Yildiz, R.
    Yamac, D.
    Ozturk, B.
    Kaya, A. O.
    Benekli, M.
    NEOPLASMA, 2008, 55 (01) : 65 - 70
  • [3] Capecitabine and oxaliplatin (XELOX) as first line treatment for patients with metastatic colorectal cancer (MCRC)
    Karacetin, D.
    Maral, O.
    Yalcyn, B.
    Okten, B.
    Incekara, O.
    ANNALS OF ONCOLOGY, 2006, 17 : 73 - 73
  • [4] Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer
    Karacetin, D.
    Yalcin, B.
    Okten, B.
    Ozturk, S.
    Maral, O.
    Incekara, O.
    JOURNAL OF BUON, 2009, 14 (04): : 605 - 608
  • [5] Phase II study of biweekly XELOX (capecitabine and oxaliplatin) as first line chemotherapy in elderly patients with metastatic colorectal cancer
    Grande, C., Sr.
    Quintero, G.
    Mel, J. R.
    Huidobro, G.
    Campos, B.
    Candamio, S.
    Mendez, J. C.
    Salgado, M.
    Alvarez, E.
    Casal, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients:: phase II study
    Santini, Daniele
    Vincenzi, Bruno
    Schiavon, Gaia
    Di Seri, Marisa
    Virzi, Vladimir
    Spalletta, Bruno
    Caricato, Marco
    Coppola, Roberto
    Tonini, Giuseppe
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (05) : 613 - 620
  • [7] Chronomodulated oxaliplatin plus Capecitabine (XELOX) as a first line chemotherapy in metastatic colorectal cancer: A Phase II Brunch regimen study
    Kezban Nur Pilancı
    Sezer Saglam
    Alper Okyar
    Serap Yucel
    Zeliha Pala-Kara
    Cetin Ordu
    Esat Namal
    Rumeysa Ciftci
    Ulkuhan Iner-Koksal
    Esra Kaytan-Saglam
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 143 - 150
  • [8] Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study
    Daniele Santini
    Bruno Vincenzi
    Gaia Schiavon
    Marisa Di Seri
    Vladimir Virzí
    Bruno Spalletta
    Marco Caricato
    Roberto Coppola
    Giuseppe Tonini
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 613 - 620
  • [9] CAPECITABINE AND OXALIPLATIN (XELOX) COMBINATION CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER-A PHASE II STUDY
    Tawfik, Hesham
    El-Deen, Hanan Gamal
    ANNALS OF ONCOLOGY, 2012, 23 : 98 - 98
  • [10] Chronomodulated oxaliplatin plus Capecitabine (XELOX) as a first line chemotherapy in metastatic colorectal cancer: A Phase II Brunch regimen study
    Pilanci, Kezban Nur
    Saglam, Sezer
    Okyar, Alper
    Yucel, Serap
    Pala-Kara, Zeliha
    Ordu, Cetin
    Namal, Esat
    Ciftci, Rumeysa
    Iner-Koksal, Ulkuhan
    Kaytan-Saglam, Esra
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (01) : 143 - 150
12345